Results

Total Results: 1,884 records

Showing results for "states".
Users also searched for: statin

321. Psoriasis-Chronic Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
     November 01, 2012 - These data were from a single RCT conducted outside the United States in patients with moderate to … Only one of these seven studies was conducted 10 in the United States, and therefore the overall … Two of the three studies were conducted outside the United States, and therefore, the overall literature … Future studies should include a population more generalizable to the United States. … conducted in other countries, where clinical practice may not reflect practice within the United States

322. CER 210: Disposition of Comments for Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
     January 01, 2020 - Is there a different risk of breast cancer inherent in being from Asia vs United States? … & Affiliation Section Comment Response Peer Reviewer 4 Results For several tables, the SOE entry states … In multiple places it states that studies were from high and very high income countries. … We have edited this bullet for clarity but have not used the word “impacts”; it now states that “…4 … The Cohen article is not a controlled trial, but there is nothing in the methods section that states

323. Disposition of Comments Report for Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
     January 01, 2014 - This bullet states that both ticagrelor and prasugrel were associated with lower individual endpoints … This bullet states that both ticagrelor and prasugrel were associated with lower individual endpoints … This sentence states that there are mixed results with ticagrelor without providing the appropriate … Page 188-9 Last sentence on page 188 states that the cost-effectiveness of ticagrelor is not known. … state that cost- effectiveness of ticagrelor versus generic clopidogrel is not known in the United States

324. Disposition of Comments_Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
     November 07, 2023 - Technical Expert #4 Methods Page 6 lines 32-33 states medications with off-label uses were limited … to those “currently in use in the United States,” then provides a list of medications from the previous … observed when stratifying on risk-of-bias or treatment duration, but studies conducted in the United States … None of the three studies conducted in the United States showed a benefit for acamprosate Revised.

325. Contrast-Induced Nephropathy (CIN): Current State of the Evidence on Contrast Media and Prevention of CIN (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_clinician.pdf
     August 01, 2016 - Contrast-Induced Nephropathy (CIN): Current State of the Evidence on Contrast Media and Prevention of CIN Focus of This Summary This is a summary of two systematic reviews. One review evaluated the evidence regarding the comparative effects of different contrast media in patients requiring diagnostic imaging studies…

326. Treatments for Fecal Incontinence: Current State of the Evidence | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/fecal-incontinence/clinician

327. Diagnosis and Management of Gout: Current State of the Evidence | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/gout/clinician

328. Management of Postpartum Hemorrhage: Current State of the Evidence | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hemorrhage-postpartum/clinician

329. Diagnosis of Celiac Disease: Current State of the Evidence | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/celiac-disease/clinician

330. Nonpharmacological Versus Pharmacological Treatment for Patients With Major Depressive Disorder: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_clinician.pdf
     September 01, 2016 - Nonpharmacological Versus Pharmacological Treatment for Patients With Major Depressive Disorder: Current State of the Evidence Nonpharmacological Versus Pharmacological Treatment for Patients With Major Depressive Disorder: Current State of the Evidence Focus of This Summary This is a summary of a systematic revie…

331. Disposition of Comments Report for Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
     March 07, 2012 - Thanks Peer Reviewer #1 Results Page 18 - 3rd paragraph states that 2 of the studies assessed different … The ANA test is performed by hundreds of different laboratories across the United States. … indirect immunofluorescence, the fact is that probably fewer than 50% of pediatricians in the United States … This is in contrast with the information provided in results section (page 12, lines 32-35), which states

332. Ptsd-Adults-Trauma-Interventions Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adults-trauma-interventions_research-protocol.pdf
     November 08, 2012 - Washington, DC: United States Department of Veterans Affairs; 2010. … Washington, DC: United States Department of Veterans Affairs; 2010. … Washington, DC: United States Department of Veterans Affairs; 2010. … Washington, DC: United States Department of Veterans Affairs; 2010. … Washington, DC: United States Department of Veterans Affairs; 2010.

333. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
     January 01, 2014 - developed for technologies and programs that appear to be closer to diffusion into practice in the United States … with some preliminary efficacy data on the target population for devices and programs) in the United States … 750,000 patients who have gout and who initiate uric acid-lowering drug therapy annually in the United States … Administration (FDA) was available at the time this report was prepared; however, one financial analyst states

334. Treatment of Osteoarthritis of the Knee: An Update Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-knee-update-disposition-archived.pdf
     May 04, 2017 - It states the searches commenced with the year 2006 but what was the end date of the reviews? … TEP Reviewer #4 Results The methods section (page 50) also states that for strength/resistance … Guideline states that there is a lack of “compelling evidence” for their use. … Arthritis care & research 64.4 (2012): 465- 474. *** Guideline states, “We conditionally recommend … Guideline states that there is a lack of “compelling evidence” for their use.

335. Treatment of Osteoarthritis of the Knee: An Update Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/osteoarthritis-knee-update-disposition.pdf
     May 04, 2017 - It states the searches commenced with the year 2006 but what was the end date of the reviews? … TEP Reviewer #4 Results The methods section (page 50) also states that for strength/resistance … Guideline states that there is a lack of “compelling evidence” for their use. … Arthritis care & research 64.4 (2012): 465- 474. *** Guideline states, “We conditionally recommend … Guideline states that there is a lack of “compelling evidence” for their use.

336. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1506.pdf
     December 01, 2015 - developed for technologies and programs that appear to be close to diffusion into practice in the United States … or for which some preliminary efficacy data in the target population are available) in the United States … HCV has six genotypes, with genotype 1 accounting for about 70% of HCV infections in the United States … Of the 1 million people with HIV infection in the United States, about 50,000 also have chronic HCV … However, its 2015 Preferred Drug Exclusions List states that Sovaldi may be covered in patients who

337. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
     July 01, 2013 - developed for technologies and programs that appear to be close to diffusion into practice in the United States … or for which some preliminary efficacy data in the target population are available) in the United States … Administration (FDA)-approved antiobesity pharmacotherapy available for long-term use in the United States … Obesity Unmet need: The increasing prevalence of overweight and obese populations in the United States … absorption, was the only FDA-approved antiobesity drug available for long-term use in the United States

338. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
     December 22, 2014 - developed for technologies and programs that appear to be close to diffusion into practice in the United States … or for which some preliminary efficacy data in the target population are available) in the United States … Waning efficacy, safety concerns, and poor risk-to-reward ratio for patients in the United States were … Of the 1 million people with chronic HIV infection in the United States, about 50,000 also have chronic … Additionally the drug’s prescribing information states that 8 weeks of ledipasvir/sofosbuvir therapy

339. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0319_06-17-2009.pdf
     January 01, 2009 - Description Nominator: Health care professional association Nomination Summary: The nominator states

340. Topic 0533 Postpartum Hemorrhage NSD FINALsj (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0652-131114.pdf
     May 15, 2013 - In addition, the nominator states that current clinical guidelines may be out of date due to the availability